nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Lisinopril—systemic scleroderma	0.198	0.328	CbGbCtD
Vecuronium—ABCB1—Captopril—systemic scleroderma	0.148	0.246	CbGbCtD
Vecuronium—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.117	0.194	CbGbCtD
Vecuronium—ABCB1—Prednisone—systemic scleroderma	0.0933	0.155	CbGbCtD
Vecuronium—ABCB1—Methotrexate—systemic scleroderma	0.0468	0.0776	CbGbCtD
Vecuronium—Steroid myopathy—Prednisone—systemic scleroderma	0.025	0.0629	CcSEcCtD
Vecuronium—Drug ineffective—Mycophenolate mofetil—systemic scleroderma	0.0245	0.0616	CcSEcCtD
Vecuronium—Muscle atrophy—Prednisone—systemic scleroderma	0.0122	0.0307	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.00677	0.017	CcSEcCtD
Vecuronium—Apnoea—Mycophenolic acid—systemic scleroderma	0.00634	0.016	CcSEcCtD
Vecuronium—Myopathy—Mycophenolate mofetil—systemic scleroderma	0.00605	0.0152	CcSEcCtD
Vecuronium—Bronchospasm—Pentoxifylline—systemic scleroderma	0.00557	0.014	CcSEcCtD
Vecuronium—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.00547	0.0138	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Captopril—systemic scleroderma	0.00513	0.0129	CcSEcCtD
Vecuronium—Apnoea—Mycophenolate mofetil—systemic scleroderma	0.00501	0.0126	CcSEcCtD
Vecuronium—Bronchospasm—Mometasone—systemic scleroderma	0.0048	0.0121	CcSEcCtD
Vecuronium—Muscular weakness—Captopril—systemic scleroderma	0.00438	0.011	CcSEcCtD
Vecuronium—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.00432	0.0109	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.00423	0.0106	CcSEcCtD
Vecuronium—Bronchospasm—Captopril—systemic scleroderma	0.00422	0.0106	CcSEcCtD
Vecuronium—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00422	0.0106	CcSEcCtD
Vecuronium—Flushing—Pentoxifylline—systemic scleroderma	0.00421	0.0106	CcSEcCtD
Vecuronium—Myopathy—Prednisone—systemic scleroderma	0.0041	0.0103	CcSEcCtD
Vecuronium—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00409	0.0103	CcSEcCtD
Vecuronium—Erythema—Pentoxifylline—systemic scleroderma	0.00394	0.00994	CcSEcCtD
Vecuronium—Face oedema—Mycophenolic acid—systemic scleroderma	0.00377	0.00949	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00363	0.00915	CcSEcCtD
Vecuronium—Angioedema—Pentoxifylline—systemic scleroderma	0.0036	0.00908	CcSEcCtD
Vecuronium—Immune system disorder—Mometasone—systemic scleroderma	0.00353	0.0089	CcSEcCtD
Vecuronium—Mediastinal disorder—Mometasone—systemic scleroderma	0.00352	0.00888	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—systemic scleroderma	0.00346	0.00871	CcSEcCtD
Vecuronium—Muscular weakness—Mycophenolic acid—systemic scleroderma	0.00344	0.00867	CcSEcCtD
Vecuronium—Face oedema—Lisinopril—systemic scleroderma	0.00339	0.00855	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00333	0.0084	CcSEcCtD
Vecuronium—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00322	0.00811	CcSEcCtD
Vecuronium—Flushing—Captopril—systemic scleroderma	0.00319	0.00803	CcSEcCtD
Vecuronium—Shock—Pentoxifylline—systemic scleroderma	0.00317	0.00798	CcSEcCtD
Vecuronium—Tachycardia—Pentoxifylline—systemic scleroderma	0.00314	0.00791	CcSEcCtD
Vecuronium—Skin disorder—Pentoxifylline—systemic scleroderma	0.00313	0.00788	CcSEcCtD
Vecuronium—Angioedema—Mometasone—systemic scleroderma	0.00311	0.00783	CcSEcCtD
Vecuronium—Hypotension—Pentoxifylline—systemic scleroderma	0.00301	0.00758	CcSEcCtD
Vecuronium—Bronchospasm—Lisinopril—systemic scleroderma	0.00299	0.00753	CcSEcCtD
Vecuronium—Face oedema—Mycophenolate mofetil—systemic scleroderma	0.00297	0.00749	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—systemic scleroderma	0.00284	0.00714	CcSEcCtD
Vecuronium—Connective tissue disorder—Leflunomide—systemic scleroderma	0.00278	0.00701	CcSEcCtD
Vecuronium—Anaphylactic shock—Mometasone—systemic scleroderma	0.00278	0.007	CcSEcCtD
Vecuronium—Angioedema—Captopril—systemic scleroderma	0.00273	0.00688	CcSEcCtD
Vecuronium—Muscular weakness—Mycophenolate mofetil—systemic scleroderma	0.00272	0.00684	CcSEcCtD
Vecuronium—Immune system disorder—Azathioprine—systemic scleroderma	0.00271	0.00682	CcSEcCtD
Vecuronium—Mediastinal disorder—Azathioprine—systemic scleroderma	0.0027	0.0068	CcSEcCtD
Vecuronium—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00265	0.00668	CcSEcCtD
Vecuronium—Cardiac disorder—Leflunomide—systemic scleroderma	0.00263	0.00662	CcSEcCtD
Vecuronium—Urticaria—Pentoxifylline—systemic scleroderma	0.00256	0.00644	CcSEcCtD
Vecuronium—Immune system disorder—Leflunomide—systemic scleroderma	0.00256	0.00644	CcSEcCtD
Vecuronium—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00255	0.00642	CcSEcCtD
Vecuronium—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00251	0.00631	CcSEcCtD
Vecuronium—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00245	0.00617	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—systemic scleroderma	0.00245	0.00617	CcSEcCtD
Vecuronium—Anaphylactic shock—Captopril—systemic scleroderma	0.00244	0.00615	CcSEcCtD
Vecuronium—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00243	0.00613	CcSEcCtD
Vecuronium—Shock—Captopril—systemic scleroderma	0.0024	0.00605	CcSEcCtD
Vecuronium—Tachycardia—Captopril—systemic scleroderma	0.00238	0.006	CcSEcCtD
Vecuronium—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00237	0.00597	CcSEcCtD
Vecuronium—Hypotension—Captopril—systemic scleroderma	0.00228	0.00574	CcSEcCtD
Vecuronium—Flushing—Lisinopril—systemic scleroderma	0.00226	0.00569	CcSEcCtD
Vecuronium—Angioedema—Leflunomide—systemic scleroderma	0.00225	0.00567	CcSEcCtD
Vecuronium—Angiopathy—Lisinopril—systemic scleroderma	0.00221	0.00556	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00221	0.00556	CcSEcCtD
Vecuronium—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00219	0.00552	CcSEcCtD
Vecuronium—Erythema—Lisinopril—systemic scleroderma	0.00212	0.00533	CcSEcCtD
Vecuronium—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00527	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00208	0.00525	CcSEcCtD
Vecuronium—Skin disorder—Azathioprine—systemic scleroderma	0.00207	0.00521	CcSEcCtD
Vecuronium—Rash—Pentoxifylline—systemic scleroderma	0.00203	0.00511	CcSEcCtD
Vecuronium—Dermatitis—Pentoxifylline—systemic scleroderma	0.00203	0.00511	CcSEcCtD
Vecuronium—Face oedema—Prednisone—systemic scleroderma	0.00202	0.00508	CcSEcCtD
Vecuronium—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00201	0.00506	CcSEcCtD
Vecuronium—Hypotension—Azathioprine—systemic scleroderma	0.00199	0.00501	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00199	0.00501	CcSEcCtD
Vecuronium—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00498	CcSEcCtD
Vecuronium—Nervous system disorder—Leflunomide—systemic scleroderma	0.00197	0.00497	CcSEcCtD
Vecuronium—Tachycardia—Leflunomide—systemic scleroderma	0.00196	0.00494	CcSEcCtD
Vecuronium—Skin disorder—Leflunomide—systemic scleroderma	0.00195	0.00492	CcSEcCtD
Vecuronium—Angioedema—Lisinopril—systemic scleroderma	0.00193	0.00487	CcSEcCtD
Vecuronium—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00487	CcSEcCtD
Vecuronium—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00484	CcSEcCtD
Vecuronium—Shock—Mycophenolic acid—systemic scleroderma	0.00189	0.00475	CcSEcCtD
Vecuronium—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00188	0.00474	CcSEcCtD
Vecuronium—Hypotension—Leflunomide—systemic scleroderma	0.00188	0.00473	CcSEcCtD
Vecuronium—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00187	0.00472	CcSEcCtD
Vecuronium—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00186	0.00469	CcSEcCtD
Vecuronium—Muscular weakness—Prednisone—systemic scleroderma	0.00184	0.00464	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.0018	0.00454	CcSEcCtD
Vecuronium—Hypotension—Mycophenolic acid—systemic scleroderma	0.00179	0.00451	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00179	0.00451	CcSEcCtD
Vecuronium—Rash—Mometasone—systemic scleroderma	0.00175	0.00441	CcSEcCtD
Vecuronium—Dermatitis—Mometasone—systemic scleroderma	0.00175	0.00441	CcSEcCtD
Vecuronium—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00173	0.00435	CcSEcCtD
Vecuronium—Shock—Lisinopril—systemic scleroderma	0.0017	0.00428	CcSEcCtD
Vecuronium—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00427	CcSEcCtD
Vecuronium—Tachycardia—Lisinopril—systemic scleroderma	0.00169	0.00425	CcSEcCtD
Vecuronium—Skin disorder—Lisinopril—systemic scleroderma	0.00168	0.00423	CcSEcCtD
Vecuronium—Hypotension—Lisinopril—systemic scleroderma	0.00161	0.00407	CcSEcCtD
Vecuronium—Urticaria—Leflunomide—systemic scleroderma	0.0016	0.00402	CcSEcCtD
Vecuronium—Hypersensitivity—Azathioprine—systemic scleroderma	0.00157	0.00395	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00395	CcSEcCtD
Vecuronium—Rash—Captopril—systemic scleroderma	0.00154	0.00387	CcSEcCtD
Vecuronium—Dermatitis—Captopril—systemic scleroderma	0.00154	0.00387	CcSEcCtD
Vecuronium—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00381	CcSEcCtD
Vecuronium—Shock—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00375	CcSEcCtD
Vecuronium—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00374	CcSEcCtD
Vecuronium—Hypersensitivity—Leflunomide—systemic scleroderma	0.00148	0.00373	CcSEcCtD
Vecuronium—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00372	CcSEcCtD
Vecuronium—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00147	0.0037	CcSEcCtD
Vecuronium—Connective tissue disorder—Prednisone—systemic scleroderma	0.00142	0.00358	CcSEcCtD
Vecuronium—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00356	CcSEcCtD
Vecuronium—Urticaria—Lisinopril—systemic scleroderma	0.00137	0.00346	CcSEcCtD
Vecuronium—Rash—Azathioprine—systemic scleroderma	0.00134	0.00338	CcSEcCtD
Vecuronium—Dermatitis—Azathioprine—systemic scleroderma	0.00134	0.00338	CcSEcCtD
Vecuronium—Flushing—Prednisone—systemic scleroderma	0.00134	0.00338	CcSEcCtD
Vecuronium—Angiopathy—Prednisone—systemic scleroderma	0.00131	0.0033	CcSEcCtD
Vecuronium—Immune system disorder—Prednisone—systemic scleroderma	0.0013	0.00329	CcSEcCtD
Vecuronium—Hypersensitivity—Lisinopril—systemic scleroderma	0.00127	0.00321	CcSEcCtD
Vecuronium—Rash—Leflunomide—systemic scleroderma	0.00127	0.00319	CcSEcCtD
Vecuronium—Dermatitis—Leflunomide—systemic scleroderma	0.00127	0.00319	CcSEcCtD
Vecuronium—Erythema—Prednisone—systemic scleroderma	0.00126	0.00317	CcSEcCtD
Vecuronium—Rash—Mycophenolic acid—systemic scleroderma	0.00121	0.00305	CcSEcCtD
Vecuronium—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00121	0.00304	CcSEcCtD
Vecuronium—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00303	CcSEcCtD
Vecuronium—Angioedema—Prednisone—systemic scleroderma	0.00115	0.00289	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—systemic scleroderma	0.00112	0.00282	CcSEcCtD
Vecuronium—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00281	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—systemic scleroderma	0.0011	0.00276	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—systemic scleroderma	0.00109	0.00275	CcSEcCtD
Vecuronium—Rash—Lisinopril—systemic scleroderma	0.00109	0.00274	CcSEcCtD
Vecuronium—Dermatitis—Lisinopril—systemic scleroderma	0.00109	0.00274	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00109	0.00274	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00106	0.00268	CcSEcCtD
Vecuronium—Erythema—Methotrexate—systemic scleroderma	0.00105	0.00265	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisone—systemic scleroderma	0.00103	0.00258	CcSEcCtD
Vecuronium—Shock—Prednisone—systemic scleroderma	0.00101	0.00254	CcSEcCtD
Vecuronium—Nervous system disorder—Prednisone—systemic scleroderma	0.00101	0.00253	CcSEcCtD
Vecuronium—Tachycardia—Prednisone—systemic scleroderma	0.001	0.00252	CcSEcCtD
Vecuronium—Skin disorder—Prednisone—systemic scleroderma	0.000997	0.00251	CcSEcCtD
Vecuronium—Rash—Mycophenolate mofetil—systemic scleroderma	0.000954	0.0024	CcSEcCtD
Vecuronium—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000954	0.0024	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000888	0.00224	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000858	0.00216	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—systemic scleroderma	0.000841	0.00212	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—systemic scleroderma	0.000833	0.0021	CcSEcCtD
Vecuronium—Urticaria—Prednisone—systemic scleroderma	0.000815	0.00205	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—systemic scleroderma	0.000801	0.00202	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisone—systemic scleroderma	0.000756	0.0019	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—systemic scleroderma	0.000681	0.00172	CcSEcCtD
Vecuronium—Rash—Prednisone—systemic scleroderma	0.000647	0.00163	CcSEcCtD
Vecuronium—Dermatitis—Prednisone—systemic scleroderma	0.000646	0.00163	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—systemic scleroderma	0.000632	0.00159	CcSEcCtD
Vecuronium—Rash—Methotrexate—systemic scleroderma	0.000541	0.00136	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—systemic scleroderma	0.00054	0.00136	CcSEcCtD
